latest news releases from the newsroom
Capital Research Group, Inc
TheSUBWAY.com Announces Its Stock Market Standouts List for Tuesday, June 15, 2004: XTME, CIEN, CSCO, SUNW
WESTON, Fla., June 15, 2004 (PRIMEZONE) -- TheSUBWAY.com announces the following stocks to its Stock Market Standouts List: Xtreme Companies Inc. (OTCBB:XTME), CIENA Corporation (Nasdaq:CIEN), Cisco Systems Inc. (Nasdaq:CSCO), Sun Microsystems Inc. (Nasdaq:SUNW).
Capital Research Group, Inc
Early Stock Market Alerts for Tuesday, June 15, 2004: XTME, BRCM, ORCL, PMCS
WESTON, Fla., June 15, 2004 (PRIMEZONE) -- TheSUBWAY.com names the following stocks to its Stock Alerts List: Xtreme Companies Inc. (OTCBB:XTME), Broadcom Corporation (Nasdaq:BRCM), Oracle Corporation (Nasdaq:ORCL), PMC-Sierra Inc. (Nasdaq:PMCS).
ViroPharma Incorporated Extends Expiration Date Until June 21, 2004
EXTON, Pa., June 15, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM), a pharmaceutical company focused on developing and commercializing products that address serious diseases treated by physician specialists and in hospital settings, including cytomegalovirus (CMV) and hepatitis C (HCV), today announced it is extending the expiration date of its offer to exchange up to $99,122,500 aggregate principal amount of its new 6% Convertible Senior Plus Cash Notes(SM) due 2009 for up to all of the $127,900,000 aggregate principal amount of its currently outstanding 6% Convertible Subordinated Notes.
Across America Real Estate Development Corp.
Across America Real Estate Development
DENVER, June 15, 2004 (PRIMEZONE) -- Across America Real Estate Development (Pink Sheets:AARD) announced the sale of a build to suit development project for a Family Dollar store located in Union City, Georgia. This property was sold through its subsidiary Cross Country Partners II to a third party investor for $680,000. The Company's 80% participating interest in its subsidiary generated a gross profit on the transaction. AARD provided 100% financing of the project.
Power3 Medical Products
Power3 Names Dr. Stanley H. Appel to Head Scientific Advisory Board
THE WOODLANDS, Texas, June 15, 2004 (PRIMEZONE) -- Power3 Medical Products, Inc. (OTCBB:PWRM) announces today the appointment of Stanley H. Appel, M.D. as Chairman of the Scientific Advisory Board of the Company. Dr. Appel currently holds the position of Chairman of the Department of Neurology at Baylor College of Medicine and has been instrumental in Power3's ongoing clinical validation for its neurodegenerative diagnostic test.
Discovery Laboratories, Inc.
Discovery Laboratories Announces FDA Acceptance of Surfaxin New Drug Application
DOYLESTOWN, Pa., June 15, 2004 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that the United States Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) filing for Surfaxin(r) for the prevention of Respiratory Distress Syndrome (RDS) in premature infants. The FDA has granted a Standard Review designation and has established a target date of February 13, 2005 for completion of review of the Surfaxin NDA.
OBN Holdings, Inc
OBN Holding's CEO Interviewed by Wall Street Reporter
LAS VEGAS, June 15, 2004 (PRIMEZONE) -- OBN Holdings, Inc. (OTCBB:OBNH) announced that Roger Neal Smith will be featured on "WallStreetReporter.com, live today at 8:00 am EST. "We are eager to tell our story," said Roger Neal Smith, CEO of OBN Holdings, Inc. "We are looking forward to being featured in these web formats, allowing the investing public to become aware of OBN Holdings, its structure, and vision for the future. We want to provide every opportunity to send out our message through these recognized outlets."